Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Obviously

<< Previous

Bullboard Posts

Next >>

Comment by Roadposeron Jun 14, 2024 8:48pm

110 Views

Post# 36090180

RE:RE:Obviously

tdon1229 wrote: Recall that they entered into Phase II with around $10 million CDN which was to pay for the entire study and the beginning of Phase I for GBM/NSCLC.
I guess they figure they were able to make that raise with much less data in hand, so why not now when there is so much more data and promise of more indications to come.

I believe the number was 17 million

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading